184 related articles for article (PubMed ID: 7051248)
1. Parenteral trimethoprim-sulfamethoxazole and carbenicillin as empiric therapy for neutropenic patients with cancer.
Braine HG; Stuart RK; Saral R; Lietman PS
Rev Infect Dis; 1982; 4(2):586-92. PubMed ID: 7051248
[TBL] [Abstract][Full Text] [Related]
2. Use of trimethoprim-sulfamethoxazole singly and in combination with other antibiotics in immunocompromised patients.
Young LS; Hindler J
Rev Infect Dis; 1987; 9 Suppl 2():S177-83. PubMed ID: 3554456
[TBL] [Abstract][Full Text] [Related]
3. Trimethoprim-sulfamethoxazole and trimethoprim alone for prophylaxis of infection in granulocytopenic patients.
Gurwith M; Truog K; Hinthorn D; Liu C
Rev Infect Dis; 1982; 4(2):593-601. PubMed ID: 6981175
[TBL] [Abstract][Full Text] [Related]
4. Vancomycin plus gentamicin and cotrimoxazole for prevention of infections in neutropenic cancer patients (a comparative, placebo-controlled pilot study).
Malarme M; Meunier-Carpentier F; Klastersky J
Eur J Cancer Clin Oncol; 1981 Dec; 17(12):1315-22. PubMed ID: 7040086
[No Abstract] [Full Text] [Related]
5. Carbenicillin-trimethoprim/sulfamethoxazole versus carbenicillin-gentamicin as empiric therapy of infection in granulocytopenic patients. A prospective, randomized, double-blind study.
Stuart RK; Braine HG; Lietman PS; Saral R; Fuller DJ
Am J Med; 1980 Jun; 68(6):876-85. PubMed ID: 6992570
[TBL] [Abstract][Full Text] [Related]
6. Trimethoprim-sulfamethoxazole in the prevention of infection in neutropenic patients. EORTC International Antimicrobial Therapy Project Group.
J Infect Dis; 1984 Sep; 150(3):372-9. PubMed ID: 6384377
[TBL] [Abstract][Full Text] [Related]
7. Selective gut decontamination with nalidixic acid or trimethoprim-sulfamethoxazole for infection prophylaxis in neutropenic cancer patients: relationship of efficacy to antimicrobial spectrum and timing of administration.
Bow EJ; Rayner E; Scott BA; Louie TJ
Antimicrob Agents Chemother; 1987 Apr; 31(4):551-7. PubMed ID: 3300532
[TBL] [Abstract][Full Text] [Related]
8. Trimethoprim-sulfamethoxazole therapy for Pneumocystis carinii pneumonitis in children.
Hughes WT
Rev Infect Dis; 1982; 4(2):602-7. PubMed ID: 6981176
[TBL] [Abstract][Full Text] [Related]
9. Use of trimethoprim-sulfamethoxazole for treatment of infections in patients with cancer.
Bodey GP; Grose WE; Keating MJ
Rev Infect Dis; 1982; 4(2):579-85. PubMed ID: 6981174
[TBL] [Abstract][Full Text] [Related]
10. Comparison of trimethoprim-sulfamethoxazole with ampicillin in acute infectious exacerbations of chronic bronchitis: a double-blind crossover study.
Chodosh S; Eichel B; Ellis C; Medici TC
Rev Infect Dis; 1982; 4(2):517-27. PubMed ID: 7051244
[TBL] [Abstract][Full Text] [Related]
11. [Carbenicillin-trimethoprim/sulphamethoxazole or carbenicillin-tobramycin as empirical treatment of infection in granulocytopenic patients. A controlled prospective trial (author's transl)].
Rafecas FJ; Sanz MA; Balaguer H; Santos M; Besalduch J; Martinez J; Marty ML; Gobernado M
Sangre (Barc); 1981; 26(3):335-46. PubMed ID: 7027489
[No Abstract] [Full Text] [Related]
12. Protocol for an international prospective trial of initial therapy regimens in neutropenic patients with malignant disease.
Gaya H; Klastersky J; Schimpff SC; Tattersall MH
Eur J Cancer (1965); 1975 Aug; 11suppl():1-4. PubMed ID: 767118
[No Abstract] [Full Text] [Related]
13. The use of trimethoprim-sulfamethoxazole in the treatment of chest infections.
Hughes DT; Russell NJ
Rev Infect Dis; 1982; 4(2):528-32. PubMed ID: 7051245
[TBL] [Abstract][Full Text] [Related]
14. Use of trimethoprim-sulfamethoxazole in a glucose-6-phosphate dehydrogenase-deficient population.
Markowitz N; Saravolatz LD
Rev Infect Dis; 1987; 9 Suppl 2():S218-29. PubMed ID: 3495027
[TBL] [Abstract][Full Text] [Related]
15. Use of trimethoprim-sulfamethoxazole in the treatment of Pneumocystis carinii pneumonitis in patients with acquired immunodeficiency syndrome.
Wofsy CB
Rev Infect Dis; 1987; 9 Suppl 2():S184-94. PubMed ID: 3554457
[TBL] [Abstract][Full Text] [Related]
16. Acute cystitis: a prospective study of laboratory tests and duration of therapy.
Schultz HJ; McCaffrey LA; Keys TF; Nobrega FT
Mayo Clin Proc; 1984 Jun; 59(6):391-7. PubMed ID: 6427533
[TBL] [Abstract][Full Text] [Related]
17. Coordinated multicenter study of norfloxacin versus trimethoprim-sulfamethoxazole treatment of symptomatic urinary tract infections. The Urinary Tract Infection Study Group.
J Infect Dis; 1987 Feb; 155(2):170-7. PubMed ID: 2879872
[TBL] [Abstract][Full Text] [Related]
18. Potential risks of trimethoprim-sulfamethoxazole prophylaxis in neutropenic patients.
Riou B; Richard C; Rimailho A; Auzepy P
J Infect Dis; 1985 May; 151(5):969. PubMed ID: 3872916
[No Abstract] [Full Text] [Related]
19. Trimethoprim-sulfamethoxazole in treatment of severe infections.
Salter AJ
Rev Infect Dis; 1982; 4(2):338-50. PubMed ID: 7051234
[TBL] [Abstract][Full Text] [Related]
20. Trimethoprim-sulfamethoxazole and trimethoprim alone in the prophylaxis of childhood urinary tract infection.
Smellie JM; Grüneberg RN; Normand IC; Bantock HM
Rev Infect Dis; 1982; 4(2):461-6. PubMed ID: 6981164
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
